Influenza Vaccine Market By Key Manufacturers, By Technology (Egg-based, Cell-Based), By Vaccine Type (Quadrivalent, Trivalent), By Route of Administration (Injectable, Nasal Spray) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Impact of Covid-19 Analysis on Global Outlook to 2027
Report ID: 398658 | May 2021 | No. of Pages: 120
|
Covid-19 Impact Analysis & Forecast
Covid-19 Impact Analysis on Global Influenza Vaccine Market Size is estimated to record USD 7.71 Billion by 2027, at a Compound Annual Growth Rate (CAGR) of 6.82%.
Covid-19 Impact Analysis on Influenza Vaccine Market report (2019-2027) includes global market size, trends, company overview, competition analysis, and forecast. The global market is projected to record USD 4.55 Billion in 2019.
The market report includes Covid-19 Impact Analysis on Influenza Vaccine Market definition, segmentation, executive summary, value chain analysis, porter’s analysis, research methodology and new industry trends which includes drivers, restraints and market opportunities. Other section includes regional analysis which is conducted on various factors such as cost of the Form/Others, raw material supplies, capacities, availability and demand analysis. Further section includes analysis and opportunity assessment for key companies. This section includes competition analysis, market share analysis, key developments of the industry, and company profiling. Within company profiling, detailed analysis of key players including company overview, Trivalent information analysis, offerings, and recent development of company. This also includes SWOT analysis that highlights the current position of company among competitors and in market.
Covid-19 Impact Analysis on Influenza Vaccine Market Dynamics
The market report comprises of market Dynamics/trends section that includes driving factors, restraints, and opportunities faced by the market players and stakeholders. These market trends includes core factors such as driving factor and restraining factor and extrinsic factors such as opportunities. These factors are not only confined with the current market situation as well as with the forecasted period.
Covid-19 Impact Analysis on Influenza Vaccine Market Competition Oralscape
The key companies in Influenza Vaccine Market are AstraZeneca Plc., Biodiem, CSL Limited, Emergent BioSolutions, F. Hoffmann-La Roche Ltd, Gamma Vaccines Pty Ltd., GlaxoSmithKline Plc., Merck & Co., Inc. (Merck Sharp & Dohme Corp.), Novartis AG, Pfizer, Inc., Sanofi Pasteur SA, and Sinovac Biotech Ltd
Focus Areas of Market
• Global Market Analysis (2019-2027)
• Cost Analysis
• Market Growth Factors
• Market Strategies
• Key Companies Analysis
• Industry Growth Analysis
Regional Analysis
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Company Profile Inclusions
• Business Overview
• Trivalent Analysis
• Market Share Analysis
• Recent News
• SWOT Analysis
Covid-19 Impact Analysis on Influenza Vaccine Market report (2019-2027) includes global market size, trends, company overview, competition analysis, and forecast. The global market is projected to record USD 4.55 Billion in 2019.
The market report includes Covid-19 Impact Analysis on Influenza Vaccine Market definition, segmentation, executive summary, value chain analysis, porter’s analysis, research methodology and new industry trends which includes drivers, restraints and market opportunities. Other section includes regional analysis which is conducted on various factors such as cost of the Form/Others, raw material supplies, capacities, availability and demand analysis. Further section includes analysis and opportunity assessment for key companies. This section includes competition analysis, market share analysis, key developments of the industry, and company profiling. Within company profiling, detailed analysis of key players including company overview, Trivalent information analysis, offerings, and recent development of company. This also includes SWOT analysis that highlights the current position of company among competitors and in market.
Covid-19 Impact Analysis on Influenza Vaccine Market Dynamics
The market report comprises of market Dynamics/trends section that includes driving factors, restraints, and opportunities faced by the market players and stakeholders. These market trends includes core factors such as driving factor and restraining factor and extrinsic factors such as opportunities. These factors are not only confined with the current market situation as well as with the forecasted period.
Covid-19 Impact Analysis on Influenza Vaccine Market Competition Oralscape
The key companies in Influenza Vaccine Market are AstraZeneca Plc., Biodiem, CSL Limited, Emergent BioSolutions, F. Hoffmann-La Roche Ltd, Gamma Vaccines Pty Ltd., GlaxoSmithKline Plc., Merck & Co., Inc. (Merck Sharp & Dohme Corp.), Novartis AG, Pfizer, Inc., Sanofi Pasteur SA, and Sinovac Biotech Ltd
Focus Areas of Market
• Global Market Analysis (2019-2027)
• Cost Analysis
• Market Growth Factors
• Market Strategies
• Key Companies Analysis
• Industry Growth Analysis
Regional Analysis
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Company Profile Inclusions
• Business Overview
• Trivalent Analysis
• Market Share Analysis
• Recent News
• SWOT Analysis
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
4.4. Covid-19 Impact Analysis on Market
Chapter 5. Covid-19 Impact Analysis on Influenza Vaccine Market Industry, By Technology
5.1. Covid-19 Impact Analysis on Influenza Vaccine Market, By Technology 2019-2027
5.2. Egg-based
5.3. Cell-Based
Chapter 6. Covid-19 Impact Analysis on Influenza Vaccine Market Industry, By Vaccine Type
6.1. Covid-19 Impact Analysis on Influenza Vaccine Market, By Vaccine Type 2019-2027
6.2. Quadrivalent
6.3. Trivalent
Chapter 7. Covid-19 Impact Analysis on Influenza Vaccine Market Industry, By Route of Administration
7.1. Covid-19 Impact Analysis on Influenza Vaccine Market, By Route of Administration 2019-2027
7.2. Injectable
7.3. Nasal Spray
Chapter 7. Covid-19 Impact Analysis on Influenza Vaccine Market Industry, By Region
8.1. Covid-19 Impact Analysis on Influenza Vaccine Market, By Region 2019-2027
8.1.1. North America
8.1.1.1. U.S
8.1.1.1. Canada
8.1.1.2. Mexico
8.1.2. Europe
8.1.2.1. U.K.
8.1.2.2. Germany
8.1.2.3. France
8.1.2.4. Rest of the Europe
8.1.3. Middle East & Africa (MEA)
8.1.3.1. GCC
8.1.3.2. North Africa
8.1.3.3. South Africa
8.1.3.4. Rest of MEA
8.1.4. Latin America (LATAM)
8.1.4.1. Brazil
8.1.4.2. Rest of LATAM
8.1.5. Asia Pacific (APAC)
8.1.5.1. India
8.1.5.2. China
8.1.5.3. Japan
8.1.5.4. Rest of the APAC
Chapter 9. Competitive Oralscape
9.1.1. Key Strategies Adopted by Players
9.1.2. Market Share/Positioning Analysis
Chapter 10. Company Profiles
10.1. AstraZeneca Plc.
10.1.2. Form Offerings
10.1.3. Trivalent PerFormance
10.1.4. Recent Initiatives
10.2. Biodiem
10.3. CSL Limited
10.4. Emergent BioSolutions
10.5. F. Hoffmann-La Roche Ltd
10.6. Gamma Vaccines Pty Ltd.
10.7. GlaxoSmithKline Plc.
10.8. Merck & Co., Inc
10.9. Novartis AG
10.10. Pfizer, Inc.
10.11. Sanofi Pasteur SA
10.12. Sinovac Biotech Ltd
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
11.3. Disclaimer
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
4.4. Covid-19 Impact Analysis on Market
Chapter 5. Covid-19 Impact Analysis on Influenza Vaccine Market Industry, By Technology
5.1. Covid-19 Impact Analysis on Influenza Vaccine Market, By Technology 2019-2027
5.2. Egg-based
5.3. Cell-Based
Chapter 6. Covid-19 Impact Analysis on Influenza Vaccine Market Industry, By Vaccine Type
6.1. Covid-19 Impact Analysis on Influenza Vaccine Market, By Vaccine Type 2019-2027
6.2. Quadrivalent
6.3. Trivalent
Chapter 7. Covid-19 Impact Analysis on Influenza Vaccine Market Industry, By Route of Administration
7.1. Covid-19 Impact Analysis on Influenza Vaccine Market, By Route of Administration 2019-2027
7.2. Injectable
7.3. Nasal Spray
Chapter 7. Covid-19 Impact Analysis on Influenza Vaccine Market Industry, By Region
8.1. Covid-19 Impact Analysis on Influenza Vaccine Market, By Region 2019-2027
8.1.1. North America
8.1.1.1. U.S
8.1.1.1. Canada
8.1.1.2. Mexico
8.1.2. Europe
8.1.2.1. U.K.
8.1.2.2. Germany
8.1.2.3. France
8.1.2.4. Rest of the Europe
8.1.3. Middle East & Africa (MEA)
8.1.3.1. GCC
8.1.3.2. North Africa
8.1.3.3. South Africa
8.1.3.4. Rest of MEA
8.1.4. Latin America (LATAM)
8.1.4.1. Brazil
8.1.4.2. Rest of LATAM
8.1.5. Asia Pacific (APAC)
8.1.5.1. India
8.1.5.2. China
8.1.5.3. Japan
8.1.5.4. Rest of the APAC
Chapter 9. Competitive Oralscape
9.1.1. Key Strategies Adopted by Players
9.1.2. Market Share/Positioning Analysis
Chapter 10. Company Profiles
10.1. AstraZeneca Plc.
10.1.2. Form Offerings
10.1.3. Trivalent PerFormance
10.1.4. Recent Initiatives
10.2. Biodiem
10.3. CSL Limited
10.4. Emergent BioSolutions
10.5. F. Hoffmann-La Roche Ltd
10.6. Gamma Vaccines Pty Ltd.
10.7. GlaxoSmithKline Plc.
10.8. Merck & Co., Inc
10.9. Novartis AG
10.10. Pfizer, Inc.
10.11. Sanofi Pasteur SA
10.12. Sinovac Biotech Ltd
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
11.3. Disclaimer
1. AstraZeneca Plc.
2. Biodiem
3. CSL Limited
4. Emergent BioSolutions
5. F. Hoffmann-La Roche Ltd
6. Gamma Vaccines Pty Ltd.
7. GlaxoSmithKline Plc.
8. Merck & Co., Inc
9. Novartis AG
10. Pfizer, Inc.
11. Sanofi Pasteur SA
12. Sinovac Biotech Ltd
2. Biodiem
3. CSL Limited
4. Emergent BioSolutions
5. F. Hoffmann-La Roche Ltd
6. Gamma Vaccines Pty Ltd.
7. GlaxoSmithKline Plc.
8. Merck & Co., Inc
9. Novartis AG
10. Pfizer, Inc.
11. Sanofi Pasteur SA
12. Sinovac Biotech Ltd
1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
3. It provides a forward looking perspective on different factors driving or restraining market growth
4. It provides an eight-year forecast assessed on the basis of how the market is expected to grow
5. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segment
6. Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Connect With Us
+1-707-633-0404
sales@search4research.com
Related reports
|
|
(COVID Version) Global Cotton Buds Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 105
|
$3000Buy Now |
|
|
(COVID Version) Global Cotton Balls and Swabs Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 110
|
$3000Buy Now |
|
|
(COVID Version) Global Cosmetic Surgery Equipment Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 108
|
$3000Buy Now |
|
|
(COVID Version) Global Cosmetic Prostheses Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 100
|
$3000Buy Now |
|
|
(COVID Version) Global Cortisone Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 103
|
$3000Buy Now |